US Pharma MarketingExclusive: Can AI chop clinical trial timelines in half? Faro raises $37M to find out
Faro AI raises $37M Series B led by Merck Global Health Innovation Fund and S32 to cut clinical trial timelines by 50% in five years using AI. Topic Hubs AI drug discovery: News, analysis and interviews Antibody-drug conjugates: The next wave of targeted cancer drugs Biopharma M&A and dealmaking: Who’s buying and why Biopharma people moves: CEO changes, executive hires, board positions Biotech IPOs: Tracking the market for new public offerings Biotech venture funding: Who’s raising and where the money is going Cell and gene therapy manufacturing: Scaling the next frontier China biotech: Licensing deals and the Biosecure Act CRISPR…
Countless startups are using AI to design molecules faster and cheaper. Far fewer are trying to address what comes next: the long slog of clinical trials.
San Diego-based Faro AI has been working on the ...
Source: Endpoints News